Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

37.73
+0.38461.03%
Post-market: 37.730.00000.00%16:10 EDT
Volume:1K
Turnover:38.58K
Market Cap:2.83M
PE:- -
High:37.73
Open:37.44
Low:37.44
Close:37.35
52wk High:38.70
52wk Low:23.88
Shares:75.00K
Float Shares:75.00K
Volume Ratio:0.16
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Steris PLC Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 16

Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says

MT Newswires Live
·
Sep 16

Illumina Inc Stock (ILMN) Moved Up by 7.40% on Sep 15: Drivers Behind the Movement

TradingKey
·
Sep 16

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU
·
Sep 16

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-15

Reuters
·
Sep 15

Thermo Fisher Exec Says Academic and Government Research Market Should Return to Growth in 2027 - Morgan Stanley Conference

THOMSON REUTERS
·
Sep 15

Thermo Fisher Exec Says Orders are Outpacing Revenue, Boding Well for Future Growth- Morgan Stanley Conference

THOMSON REUTERS
·
Sep 15

Mayo Clinic and Thermo Fisher Scientific Launch Precure, Llc to Identify Signs of Disease Before Symptoms Appear

THOMSON REUTERS
·
Sep 15

Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness

TIPRANKS
·
Sep 15

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Sep 15

Barclays downgrades Scholar Rock on valuation after FDA approval

TIPRANKS
·
Sep 15

Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20

Reuters
·
Sep 15

Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics

TIPRANKS
·
Sep 15

Guardant Health, - Evicore by Evernorth to Cover Shield Blood Test for Crc Screening Effective Jan 1, 2027

THOMSON REUTERS
·
Sep 15

Biofrontera announces FDA approval of Ameluz supplemental new drug application

TIPRANKS
·
Sep 14

Scholar Rock Wins FDA Approval for SMA Therapy

TIPRANKS
·
Sep 14

Scholar Rock price target raised to $84 from $76 at BMO Capital

TIPRANKS
·
Sep 14

Cellectis pivots to in vivo gene editing and exits key CAR-T programs

TIPRANKS
·
Sep 14

Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company

GlobeNewswire
·
Sep 14

Vertex Minerals Revises Timeline for Proposed Securities Issue

TIPRANKS
·
Sep 14